This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeForge, L. E. Articles by Remick, D. G. Search for Related Content PubMed PubMed Citation Articles by DeForge, L. E. Articles by Remick, D. G.

American Journal of Pathology, Vol 140, 1045-1054, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood

LE DeForge, DE Tracey, JS Kenney and DG Remick
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602.

Interleukin-8 (IL-8) is a neutrophil and lymphocyte chemoattractant and activator that may play an important role in mediating events at sites of inflammation. IL-8 is produced by many cell types in response to a variety of inducers, including interleukin-1 (IL-1). Studies were conducted to address the question of whether an inhibitor of IL-1 action, IL-1 receptor antagonist protein (IRAP), would suppress IL-8 production. Lipopolysaccharide (LPS)-stimulated human whole blood was used as an ex vivo model of local cytokine production. Preliminary time course studies showed that plasma IL-1 beta levels were fully induced by 6 hours (approximately 15 ng/ml) and persisted at this level over 24 hours. IL-8 production, in contrast, reached a plateau between 6 to 12 hours (5 ng/ml) and then increased rapidly to 17 ng/ml at 24 hours. Addition of IRAP was found to dose-dependently inhibit IL-8 expression at the levels of both protein and mRNA. A 50% reduction in IL-8 protein release occurred at an IRAP dose of 8 micrograms/ml (5 x 10(-7) mol/l) at 24 hours. A 2 hour delay in the addition of IRAP relative to LPS still permitted optimal reduction in IL-8 release, whereas delays of 4- 8 hours reduced or eliminated the inhibitory effect. IRAP was found to have no effect on the LPS-stimulated production of IL-1 alpha or IL-1 beta. In addition, experiments performed with isolated peripheral blood cells demonstrated that, whereas monocytes were the major producers of IL-8, IRAP was equally effective in reducing IL-8 production in neutrophil and mononuclear cell suspensions. These studies further document the role of IL-1 in inducing the production of IL-8 and indicate that the ability of IRAP to suppress IL-8 expression may be an important mechanism of the anti-inflammatory properties of this molecule.

This article has been cited by other articles:

				M. Hellmuth, C. Wetzler, M. Nold, J.-H. Chang, S. Frank, J. Pfeilschifter, and H. Muhl Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate Carcinogenesis, August 1, 2002; 23(8): 1273 - 1279. [Abstract] [Full Text] [PDF]

				Y. A. Schwarz, R. S. Amin, J. M. Stark, B. C. Trapnell, and R. W. Wilmott Interleukin-1 Receptor Antagonist Inhibits Interleukin-8 Expression in A549 Respiratory Epithelial Cells Infected In Vitro with a Replication-Deficient Recombinant Adenovirus Vector Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 388 - 394. [Abstract] [Full Text]